Skip to main content

Table 5 Toxicity in the Trial and Control Group

From: The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer

Toxicity Trial (n = 69) Control (n = 36) P*
  0 I II III IV 0 I II III IV  
Anemia 37 16 8 7 1 21 9 4 1 1 0.665
Leukopenia 28 23 9 9 0 17 13 4 2 0 0.570
Thrombocytopia 59 5 2 2 1 31 3 1 1 0 0.557
Nausea / Vomiting 32 16 19 2 0 18 4 11 2 1 0.476
Fever 52 12 5 0 0 36 0 0 0 0 0.000
Eruption 67 2 0 0 0 36 0 0 0 0 0.274
Cold-like symptoms 47 19 3 0 0 36 0 0 0 0 0.000
Ostealgia / Myosalgia 46 21 2 0 0 36 0 0 0 0 0.000
Chill 38 31 0 0 0 36 0 0 0 0 0.000
Pain in injection area 13 41 15 0 0 36 0 0 0 0 0.000
Hardening, swelling and redness in injection area 42 17 10 0 0 36 0 0 0 0 0.000
  1. *The p value is calculated by Fisher exact chi-square because n<30 or some cells have expected count less than 1.